VIM and colorectal carcinoma: When we further analysed the survival data for stage II (without lymph node metastasis) and stage III (with lymph node metastasis) CRC, we found that irrespective of the lymph node status, vimentin expression was significantly associated with a higher disease recurrence rate (Figure 2B).